首页 >
法规速递
-
Document: Ledipasvir/sofosbuvir film-coated tablet 45 mg/200 mg and 90 mg/400 mg, coated granules 33.75mg/150mg and 45mg/200mg product-specific bioequivalence guidance - Revision 1-2025/7/10
2025-07-11查看详情 > -
Document: CHMP PROM minutes for the meeting on 17 February 2025-2025/8/14
2025-08-15查看详情 > -
Page: List of medicines under additional monitoring-2025/9/26
2025-09-28查看详情 > -
Page: Good pharmacovigilance practices (GVP)-2025/11/4
2025-11-05查看详情 > -
Document: Veterinary Scientific Advice procedure – timelines 2026 - information for applicants-2025/12/4
2025-12-05查看详情 > -
Page: Medical devices-2026/1/12
2026-01-13查看详情 > -
Page: Paediatric investigation plans-2026/212
2026-02-13查看详情 > -
国家药监局关于同意福建、河南省药监局开展优化药品补充申请审评审批程序改革试点的批复-2026/3/24
2026-03-25查看详情 > -
Page: Expert panel support for breakthrough medical devices: pilot programme-2026/4/28
2026-04-29查看详情 > -
Document: Appendix 1: Acceptable intakes established for N-nitrosamines-2026/6/9
2026-06-10查看详情 >
